Florescu Ioan Petre, Turcu Eugen Gabriel, Carantino Andrei Mircea, Cocoşilă Laurenţiu Cătălin, Enache Valentin, Neagu Tiberiu Paul, Jecan Cristian Radu
Department of Plastic Surgery and Reconstructive Microsurgery, Emergency Clinical Hospital of Bucharest, Romania;
Rom J Morphol Embryol. 2018;59(1):345-352.
The risk of developing basal cell carcinoma (BCC) during lifetime varies between 29-55%, while for squamous cell carcinoma (SCC) varies between 7-11%. Between them, considered to be a BCC, there is a particular histological type, named metatypical basal cell carcinoma (MTC) or basosquamous cell carcinoma (BSCC). In this paper, we presented a rare case of metatypical carcinoma of the forehead with an interesting history of unexpected recurrences, underlining the clinical, therapeutic and histological essential aspects that may come in use to other clinicians in managing this type of cancer. In this case, the last recurrent tumor invaded the external layer of the frontal bone and needed a temporo-parietal flap to cover the large defect, which was previously covered in 2014 using skin grafts. Using Hematoxylin-Eosin (HE) staining, the histological assessment revealed a basosquamous carcinoma (IDO-O 8094/3, according to World Health Organization). In addition to the histological aspects revealed using HE staining, in this case, diffused tumor cells were p63 nuclear positive, which according to Bircan et al. (2006), it is strongly and diffuse reactive in 82.1% differentiated, in 77.8% of superficial and in 72.3% of solid undifferentiated BCCs. The aggressive behavior was revealed by tumor's dimension, local invasion of the frontal bone with high mitotic rate as seen in the van Gieson and HE staining, also by the number of recurrences. The prognosis of this case is reserved due to the number of recurrent tumors, immunohistochemistry anomalies, involvement of the external layer of the frontal bone, tumor site, gender, poor remaining reconstructive procedures in case of a relapse, thus, close follow-up is to be recommended for a period of minimum five years. Recurrent tumors raise treatment difficulties regarding the reconstruction procedure of the defect after wide surgical excision. Therefore, the aggressive behavior of the MTC should be taken into consideration in clinical practice.
一生中患基底细胞癌(BCC)的风险在29%至55%之间,而鳞状细胞癌(SCC)的风险在7%至11%之间。在它们之间,有一种特殊的组织学类型被认为是基底细胞癌,称为化生型基底细胞癌(MTC)或基底鳞状细胞癌(BSCC)。在本文中,我们报告了一例罕见的前额化生型癌病例,其具有意外复发的有趣病史,强调了临床、治疗和组织学方面的要点,这些要点可能对其他临床医生处理此类癌症有用。在该病例中,最后一次复发的肿瘤侵犯了额骨外层,需要颞顶皮瓣来覆盖大的缺损,该缺损在2014年曾使用皮肤移植覆盖。使用苏木精-伊红(HE)染色,组织学评估显示为基底鳞状细胞癌(根据世界卫生组织,IDO-O 8094/3)。除了HE染色显示的组织学特征外,在该病例中,弥漫性肿瘤细胞p63核呈阳性,根据Bircan等人(2006年)的研究,在82.1%的分化型、77.8%的浅表型和72.3%的实体未分化型基底细胞癌中呈强弥漫性反应。肿瘤的大小、额骨的局部侵犯以及高有丝分裂率(如在范吉森染色和HE染色中所见)以及复发次数都显示出侵袭性行为。由于复发肿瘤的数量、免疫组化异常、额骨外层受累、肿瘤部位、性别、复发时剩余重建手术不佳等原因,该病例的预后不容乐观,因此建议至少密切随访五年。复发肿瘤给广泛手术切除后缺损的重建手术带来了治疗困难。因此,在临床实践中应考虑化生型基底细胞癌的侵袭性行为。